Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants
about
Enhancement of dengue virus type 2 replication in mouse macrophage cultures by bacterial cell walls, peptidoglycans, and a polymer of peptidoglycan subunitsLipophilic derivative of muramyl dipeptide is more active than muramyl dipeptide in priming macrophages to release superoxide anion.Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice.Immunocompetent cells in resistance to bacterial infectionsStimulation of the reticuloendothelial system of mice by muramyl dipeptide.Release of soluble peptidoglycan from growing gonococci: hexaminidase and amidase activitiesMacrophage activation by bacterial cell walls and related synthetic compounds.Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptideActivity in saline of phthalylated or succinylated derivatives of mycobacterial water-soluble adjuvant.Failure of endotoxin to increase nonspecific resistance to infection of lipopolysaccharide low-responder miceAdjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds.Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compoundsAdjuvants et stimulants de l'immunité: propriétés immunorégulatrices du muramyl-dipeptide, des corynébactéries anaérobies et du diéthyldithiocarbamate de sodiumMuramyl peptides as paradigms in neuroimmunomodulation.Structure of Bordetella pertussis peptidoglycan.Protective effect of a muramyl dipeptide analog encapsulated in or mixed with liposomes against Candida albicans infectionIncreased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharideActivation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide.Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in miceAdjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs.Activation of mouse peritoneal adherent cells with N-acyl muramyl dipeptide derivatives.Processing of Bacillus subtilis peptidoglycan by a mouse macrophage cell line.Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant Echinacea purpurea.Activation of macrophages by quinonyl-N-acetylmuramyl dipeptide.Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.Stimulation of chemiluminescence by synthetic muramyl dipeptide and analogs.Stimulation of migration of human monocytes by bacterial cell walls and muramyl peptides.Species dependency of in vitro macrophage activation by bacterial peptidoglycans.Comparison of various assays to quantitate macrophage activation by biological response modifiers.
P2860
Q27487956-D6AB03EC-A4DB-4C9F-B459-9A19F46752AFQ33906747-FEC4090C-9947-4E8E-A521-7FA580B92127Q33910568-C228CF21-413D-4403-959D-D815C93B73A5Q34071629-7AF1DF60-45FD-4668-BBFA-AD20ADC63FD5Q34082722-8633260A-8543-48F5-8D5D-75944A5D45CFQ34086226-9616110E-D0F8-4C09-8A93-49BFB9D1CFDCQ34087526-4366C40F-F795-4B7C-8E53-F2E2908028CEQ34088685-287624EF-D8B5-459C-AB36-C1F1DAB5B3FBQ34136895-4E62D8B8-0101-4C6A-B01D-2A7B4B6EB047Q34389573-10FDD224-8339-4CA7-9ED1-3DC815A807E6Q34398908-074A83B7-231A-42E3-9395-AB264F1160B8Q34446761-D1602604-9D75-4996-9F38-A924B967CF63Q35192565-A820D7A9-CF2C-457B-9203-1C5186A4EA24Q36213009-F58B6961-63C8-486C-9E6F-91A0137CBF7BQ36265223-ACD77F2A-58B5-4972-9F25-41F418CCBE0CQ36341567-91CA9BF3-4D35-415D-B626-A57F3C2DCD24Q36343222-6953BD56-678A-420E-BFEA-9219A5F059AEQ36344254-96D13A2C-6B1B-4345-A631-383F9A83ADA9Q36433792-50297DC1-DEBC-4537-999E-E5D374C04476Q36443048-7C238FAF-74AE-4FB7-932E-245BDC9C8769Q36454087-7938A3AC-BA7A-4DA2-896C-8E392F80D8BCQ37036204-AAAFE397-5786-46D0-B988-9A112DE79DA2Q37041749-922AA67E-7845-4301-A922-C642C45C0121Q37043207-1A89AA03-BB4B-45D4-B46C-C20328275841Q37112048-31DD5CC1-D4B2-4E00-BE93-90A201F269F8Q37590881-3C43504B-FEAB-4DB1-AD4D-60618057D80BQ40184051-FA568E45-278C-4A31-897B-15EC878F6C96Q40599254-4047A123-D564-41C0-8706-D31E4C4AA3E2Q46780385-9AAB544F-379A-4138-94E8-EE1CF50D0C5AQ54485715-1DA46B93-0556-4BFD-A14E-7BB4F9A5B83F
P2860
Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants
description
1975 nî lūn-bûn
@nan
1975 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Comparison between macrophage ...... mycobacterial immunoadjuvants
@ast
Comparison between macrophage ...... mycobacterial immunoadjuvants
@en
type
label
Comparison between macrophage ...... mycobacterial immunoadjuvants
@ast
Comparison between macrophage ...... mycobacterial immunoadjuvants
@en
prefLabel
Comparison between macrophage ...... mycobacterial immunoadjuvants
@ast
Comparison between macrophage ...... mycobacterial immunoadjuvants
@en
P2860
P356
P1476
Comparison between macrophage ...... mycobacterial immunoadjuvants
@en
P2860
P304
P356
10.1073/PNAS.72.10.4105
P407
P577
1975-10-01T00:00:00Z